FDA Highlights Concerns About Research Investigating MDMA as PTSD Treatment

Ganjapreneur
By Graham AbbottJun 3, 2024, 10:03 am222 pts
The U.S. Food and Drug Administration (FDA) on Friday posted its initial review of the hallucinogen MDMA, commonly known as molly or ecstasy, which highlights concerns about the substance’s potential health effects when used as a treatment for post-traumatic stress disorder (PTSD), the New York Times reports.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas gov. makes final hour decision on hemp ban 69

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 62

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.